WO2024184792 - TRANSDERMAL DRUG DELIVERY SYSTEMS FOR ADMINISTRATION OF A THERAPEUTICALLY EFFECTIVE AMOUNT OF APIXABAN AND OTHER DIRECT ORAL ANTICOAGULANTS
National phase entry is expected:
Publication Number
WO/2024/184792
Publication Date
12.09.2024
International Application No.
PCT/IB2024/052081
International Filing Date
04.03.2024
Title **
[English]
TRANSDERMAL DRUG DELIVERY SYSTEMS FOR ADMINISTRATION OF A THERAPEUTICALLY EFFECTIVE AMOUNT OF APIXABAN AND OTHER DIRECT ORAL ANTICOAGULANTS
[French]
SYSTÈMES D'ADMINISTRATION TRANSDERMIQUE DE MÉDICAMENT POUR L'ADMINISTRATION D'UNE QUANTITÉ THÉRAPEUTIQUEMENT EFFICACE D'APIXABAN ET D'AUTRES ANTICOAGULANTS ORAUX DIRECTS
Applicants **
PIKE THERAPEUTICS INC.
Inventors
PLAKOGIANNIS, Fotios M.
MODI, Nisarg
PLAKOGIANNIS, Rodoula
LATHER, Tamanna
Priority Data
63/450,515
07.03.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CIPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4439 | |
| EPO | Filing, Examination, Granting | 83919 | |
| Japan | Filing, Examination, Granting | 4622 | |
| South Korea | Filing, Examination, Granting | 7004 | |
| USA | Filing, Examination, Granting | 18940 |
Total:
118,924
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Method of preventing and treating thromboembolic conditions by using direct oral anticoagulants such as apixaban via transdermal, subcutaneous, intramuscular or buccal routes by avoiding the gastrointestinal tract.[French]
L'invention concerne un procédé de prévention et de traitement d'états thromboemboliques à l'aide d'anticoagulants oraux directs tels que l'apixaban par voie transdermique, sous-cutanée, intramusculaire ou buccale, en évitant le tractus gastro-intestinal.